Search research articles
Contact Us
Filters
Showing results (11-20 of 31) with videos related to
Page
of 4
Sort By:
Journal of Global Oncology
|
December 21, 2019
Expanding Coverage of Oncology Drugs in an Aging, Upper-Middle-Income Country: Analyses of Public and Private Expenditures in Chile
Veronica Vargas, Christine Leopold, Marianela Castillo-Riquelme, et al.
Journal of the National Cancer Institute
|
May 23, 2018
Defining Value of Cancer Therapeutics-A Health System Perspective
Christine Leopold, Jeffrey M Peppercorn, S Yousuf Zafar, et al.
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics
|
October 6, 2020
The Complex Cancer Care Coverage Environment - What is the Role of Legislation? A Case Study from Massachusetts
Christine Leopold, Rebecca L Haffajee, Christine Y Lu, et al.
Clinical Pharmacology and Therapeutics
|
June 24, 2026
Repurposing Registries: Completeness of Real-World Data for Regulatory and HTA Purposes in Three Cancer-Focused Registries
Manon C Wilpshaar, Doranne Hilarius, Luisa Prada, et al.
Health Affairs Scholar
|
March 19, 2026
A multi-stakeholder survey on communicating cost-effectiveness uncertainties to stakeholders: a case study of ICER
Jan-Willem Versteeg, Wim G Goettsch, Aukje K Mantel-Teeuwisse, et al.
Health Policy (Amsterdam, Netherlands)
|
July 26, 2018
An analysis of expenditures on primary care prescription drugs in the United States versus ten comparable countries
Steven G Morgan, Chester B Good, Christine Leopold, et al.
International Journal of Technology Assessment in Health Care
|
November 17, 2025
Coverage with evidence development for medicines with insufficient evidence of clinical benefit: experience from the Netherlands
Jan-Willem Versteeg, Noraly Stam, Aukje K Mantel-Teeuwisse, et al.
British Journal of Clinical Pharmacology
|
May 14, 2026
Decoding RNA regulation: Challenges and opportunities for RNA-based therapies in Europe
Olivia C Lewis, Christine Leopold, Joyce M Hoek, et al.
Pharmacoeconomics
|
October 5, 2024
Managed Entry Agreements for High-Cost, One-Off Potentially Curative Therapies: A Framework and Calculation Tool to Determine Their Suitability
Marcelien H E Callenbach, Rick A Vreman, Christine Leopold, et al.
Health Policy (Amsterdam, Netherlands)
|
October 22, 2011
Differences in external price referencing in Europe: a descriptive overview
Christine Leopold, Sabine Vogler, A K Mantel-Teeuwisse, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 31) with videos related to
Sort By:
Page
of 4
Journal of Global Oncology
|
December 21, 2019
Expanding Coverage of Oncology Drugs in an Aging, Upper-Middle-Income Country: Analyses of Public and Private Expenditures in Chile
Veronica Vargas, Christine Leopold, Marianela Castillo-Riquelme, et al.
Journal of the National Cancer Institute
|
May 23, 2018
Defining Value of Cancer Therapeutics-A Health System Perspective
Christine Leopold, Jeffrey M Peppercorn, S Yousuf Zafar, et al.
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics
|
October 6, 2020
The Complex Cancer Care Coverage Environment - What is the Role of Legislation? A Case Study from Massachusetts
Christine Leopold, Rebecca L Haffajee, Christine Y Lu, et al.
Clinical Pharmacology and Therapeutics
|
June 24, 2026
Repurposing Registries: Completeness of Real-World Data for Regulatory and HTA Purposes in Three Cancer-Focused Registries
Manon C Wilpshaar, Doranne Hilarius, Luisa Prada, et al.
Health Affairs Scholar
|
March 19, 2026
A multi-stakeholder survey on communicating cost-effectiveness uncertainties to stakeholders: a case study of ICER
Jan-Willem Versteeg, Wim G Goettsch, Aukje K Mantel-Teeuwisse, et al.
Health Policy (Amsterdam, Netherlands)
|
July 26, 2018
An analysis of expenditures on primary care prescription drugs in the United States versus ten comparable countries
Steven G Morgan, Chester B Good, Christine Leopold, et al.
International Journal of Technology Assessment in Health Care
|
November 17, 2025
Coverage with evidence development for medicines with insufficient evidence of clinical benefit: experience from the Netherlands
Jan-Willem Versteeg, Noraly Stam, Aukje K Mantel-Teeuwisse, et al.
British Journal of Clinical Pharmacology
|
May 14, 2026
Decoding RNA regulation: Challenges and opportunities for RNA-based therapies in Europe
Olivia C Lewis, Christine Leopold, Joyce M Hoek, et al.
Pharmacoeconomics
|
October 5, 2024
Managed Entry Agreements for High-Cost, One-Off Potentially Curative Therapies: A Framework and Calculation Tool to Determine Their Suitability
Marcelien H E Callenbach, Rick A Vreman, Christine Leopold, et al.
Health Policy (Amsterdam, Netherlands)
|
October 22, 2011
Differences in external price referencing in Europe: a descriptive overview
Christine Leopold, Sabine Vogler, A K Mantel-Teeuwisse, et al.
Page
of 4